Features in genomics and tumor immune microenvironment in NSCLC treated with neoadjuvant PD-1 blockade.
2021
9063Background: Results from several clinical trials have preliminarily demonstrated the safety and effectiveness of single PD-1 inhibitors in neoadjuvant setting for resectable non-small cell lung...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI